Tuberculosis incidence among people living with HIV/AIDS with virological failure of antiretroviral therapy in Salvador, Bahia, Brazil

[1]  Sociedade Brasileira de Pneumologia e Tisiologia Sbpt.  Sociedade Brasileira de Pneumologia e Tisiologia , 2019 .

[2]  David P. Wilson,et al.  Determinants of virological failure after 1 year's antiretroviral therapy in Vietnamese people with HIV: findings from a retrospective cohort of 13 outpatient clinics in six provinces , 2014, Sexually Transmitted Infections.

[3]  S. Sundar,et al.  Predictive markers of failure of first line anti retroviral treatment in HIV patients in India. , 2013 .

[4]  H. Ramroth,et al.  Virological failure and drug resistance in patients on antiretroviral therapy after treatment interruption in Lilongwe, Malawi. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Nazim Madhavji,et al.  Organization , 2020, WER.

[6]  D. Mant,et al.  Associations With Virologic Treatment Failure in Adults on Antiretroviral Therapy in South Africa , 2010, Journal of acquired immune deficiency syndromes.

[7]  D. Katzenstein,et al.  Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa , 2010, AIDS (London).

[8]  M. Conde,et al.  III Brazilian Thoracic Association Guidelines on tuberculosis. , 2009, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[9]  L. Pinoges,et al.  Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda , 2009, BMC infectious diseases.

[10]  G. Maartens,et al.  Effect of rifampicin-based antitubercular therapy on nevirapine plasma concentrations in South African adults with HIV-associated tuberculosis. , 2007, The Journal of antimicrobial chemotherapy.

[11]  G. Maartens,et al.  Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome. , 2007, The Journal of infectious diseases.

[12]  K. Ruxrungtham,et al.  Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment , 2007, HIV medicine.

[13]  G. Maartens,et al.  Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[14]  Roger Detels,et al.  Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection , 1997, Annals of Internal Medicine.

[15]  M. Raviglione,et al.  Global tuberculosis incidence and mortality during 1990-2000. , 1994, Bulletin of the World Health Organization.